Solifenacin Succinate NDC 62332-193

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-193Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0193Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-193-08	62332019308	80 TABLET, COATED in 1 CARTON (62332-193-08)Marketed from May 20, 2019
62332-193-30	62332019330	30 TABLET, COATED in 1 BOTTLE (62332-193-30)Marketed from May 20, 2019
62332-193-90	62332019390	90 TABLET, COATED in 1 BOTTLE (62332-193-90)Marketed from May 20, 2019
62332-193-91	62332019391	1000 TABLET, COATED in 1 BOTTLE (62332-193-91)Marketed from May 20, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Solifenacin Succinate
Generic name (nonproprietary): solifenacin succinate
Active ingredients: Solifenacin succinate — 10 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205575
Marketing start: May 20, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 62332-193_b7806d00-75b4-482e-8e83-d71a9ca8e012SPL ID b7806d00-75b4-482e-8e83-d71a9ca8e012SPL set ID 48f82298-6600-4c69-a638-8dae15083fd9RxCUI 477367, 477372UNII KKA5DLD701
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332019308 followed by a unit qualifier and the quantity

Package 62332-0193-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 7, 2021.

Indications (excerpt from the label)

Solifenacin succinate tablet is indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205575

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205575
Product	Strength	Form · route	Labeler	Product NDC
Solifenacin Succinate	Solifenacin succinate 5 mg/1	Tablet, CoatedOral	Alembic Pharmaceuticals Limited	46708-192
Solifenacin Succinate	Solifenacin succinate 10 mg/1	Tablet, CoatedOral	Alembic Pharmaceuticals Limited	46708-193
Solifenacin Succinate	Solifenacin succinate 5 mg/1	Tablet, CoatedOral	Alembic Pharmaceuticals Inc.	62332-192